Renalytix (Renalytix) Institutional Ownership : 10.10% (As of May. 18, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Renalytix Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Renalytix's institutional ownership is 10.10%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Renalytix's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Renalytix's Float Percentage Of Total Shares Outstanding is 0.00%.

Renalytix Institutional Ownership Historical Data

The historical data trend for Renalytix's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Institutional Ownership Chart

Renalytix Historical Data

The historical data trend for Renalytix can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	8.76	8.73	8.48	8.25	7.85	7.57	7.57	7.53	10.74	10.10

Renalytix Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Renalytix (Renalytix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (OTCPK:RTNXF) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

RNLX:USA RENX:UK 2O9:Germany

Address

5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.